TP53 and breast carcinoma: In our breast cancer samples, we found that low expression of the mir-141/mir-200c cluster was associated with activated signaling via the PI3K–AKT pathway, which concurs with recent data suggesting that p53 negatively regulates the ZEB–E-cadherin pathway by upregulating mir-200s [23].